Skip to main content
Figure 6 | Kinetoplastid Biology and Disease

Figure 6

From: Consultative meeting to develop a strategy for treatment of cutaneous leishmaniasis. Institute Pasteur, Paris. 13–15 June, 2006

Figure 6

The public health aspect of paromomycin-urea ointment. The true benefit of the paromomycin (aminocidine) ointment in ZCL patients (caused by L. major) in Isfahan, Iran. About 30–40% self heal within 5–6 months from onset of disease, With an efficacy of the ointment about 35–40%, 75–80 would cure within this period leaving 20–25% of refractory patients who would need other treatment. This figure indicates the importance of a placebo (control) arm in all CL studies. In addition, the duration of lesion prior to enrolment into any trial is critical, since with time, more and more cases self heal.

Back to article page

Kinetoplastid Biology and Disease

ISSN: 1475-9292